Originally published In Press as doi:10.1074/jbc.M111922200 on February 6, 2002
J. Biol. Chem., Vol. 277, Issue 17, 14894-14901, April 26, 2002
Membrane Potential-controlled Inhibition of Cytochrome
c Oxidase by Zinc*
Denise A.
Mills
,
Bryan
Schmidt,
Carrie
Hiser,
Erica
Westley§, and
Shelagh
Ferguson-Miller¶
From the Department of Biochemistry, Michigan State University,
East Lansing, Michigan 48824-1319
Received for publication, December 14, 2001, and in revised form, January 31, 2002
 |
ABSTRACT |
Like many voltage-sensitive ion pumps, cytochrome
c oxidase is inhibited by zinc. Binding of zinc to the
outside surface of Rhodobacter sphaeroides cytochrome
c oxidase inhibits the enzyme with a KI
of
5 µM when the enzyme is reconstituted into
phospholipid vesicles in the presence of a membrane potential. In the
absence of a membrane potential and a pH gradient, millimolar concentrations of zinc are required to inhibit. This differential inhibition causes a dramatic increase in the respiratory control ratio
from 6 to 40 for wild-type oxidase. The external zinc inhibition is
removed by EDTA and is not competitive with cytochrome c
binding but is competitive with protons. Only Cd2+ of the
many metals tested (Mg2+, Mn2+,
Ca2+, Ba2+, Li2+, Cs2+,
Hg2+, Ni2+, Co2+, Cu2+
Tb3+, Tm3+) showed inhibitory effects similar
to Zn2+. Proton pumping is slower and less efficient with
zinc. The results suggest that zinc inhibits proton movement through a
proton exit path, which can allow proton back-leak at high membrane
potentials. The physiological and mechanistic significance of proton
movement in the exit pathway and its blockage by zinc is discussed in
terms of regulation of the efficiency of energy transduction.
 |
INTRODUCTION |
Zinc is observed to have an unusually strong and
specific inhibitory effect on a number of proton and ion channels, but
the physiological significance of this inhibition is the subject of much debate (1). The controversy is heightened by the difficulty in
accurately assessing free zinc levels in tissues and subcellular compartments (1, 2). In mitochondria, zinc is known to inhibit the
bc1 complex at submicromolar levels (3), and
similar strong inhibition is observed in bacterial photosynthetic
reaction centers (3, 4). In each case, the zinc inhibition is
reversible and blocks a proton pathway. In the reaction center, where
addition of Zn2+ limits a proton uptake step, the site for
zinc binding was determined by x-ray crystallography (4) allowing the
identification of the predominant route for proton uptake and two
aspartates that participate in that proton transfer pathway.
Cytochrome c oxidase
(CcO)1 requires
protons as a substrate, using 4 protons for the reduction of
O2 to form 2H2O and translocating 4 protons
across the membrane for each O2 reduced. A total of 8 protons are therefore taken up from the interior per 4 electrons donated externally by cytochrome c, the electron donor.
Crystal structures of cytochrome c oxidase have helped
identify two proposed channels for proton uptake in subunit I (5-7),
referred to as the D and K channels, because an aspartate and a lysine,
respectively, are important for their activity (Fig.
1). The roles of these channels are still
debated in terms of the number and destination of the protons they
conduct and how the individual proton uptake events are coupled to
electron transfer. Even less well understood is the pathway for proton
release, although several proposals have been made (8, 9). A
hydrogen-bonded network, the H channel, has been suggested as a
potential proton pathway that spans the membrane in the bovine oxidase
(7), but its presence in bacterial oxidases has not been confirmed
(10).

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 1.
The proposed proton paths and external
surface amino acids in R. sphaeroides cytochrome
c oxidase. A, a side view showing
the metal centers (CuA, CuB, and Mg) and hemes
are depicted with possible proton paths: K path (blue) with
residues (bottom to top) Ser-299, Lys-362,
Thr-359, and Tyr-288; Thr-352; D path (red) with residues
Asp-132, Asn-121 and Asn-139, Ser-197, and Glu-286; H path
(dashed brown arrow) with residues (yellow)
Glu-450, His-456, Ser-425 and Ser-504, Gln-471, Arg-52, Ser-497, and
Tyr-414. A tentative connection (dotted black arrow) from
the D path to possible exit paths (black solid arrows) is
shown. The outside amino acids that are also depicted in view
B are colored magenta. Arg-482 (which interacts
with the propionates of heme a, close to Arg-481) and
His-334 (CuB ligand) are shown in gray but not
labeled. B, top view showing the outside amino acids
discussed in this report with side-chain color matched to
the color of the amino acid number. The pathways,
D, K, and H, are labeled in Subunit I
(gray helices) corresponding to the apparent "pores"
identified by Iwata et al. (5). Also shown are the 2 hemes
(black wire frame), Cu and Mg (red- and
yellow-filled circles, respectively). Subunit III is
yellow and subunit IV is orange with associated
phospholipids (green wire frame). Subunit II has been
omitted for clarity, with the exception of M263II and
CuA. The figure was made using Rasmol. (The coordinates for
RsCcO were generously provided by M. Svensson-Ek, L. Rodgers, J. Abramson, S. Tonroth, P. Brzezinski, and S. Iwata, personal
communication.)
|
|
A reversible metal inhibitor that selectively binds to one of the
proton paths would be an excellent tool for elucidating the function of
the different proton transfer channels in oxidase. Although studies in
1988 (11) showed zinc inhibition of bovine heart oxidase reconstituted
into proteoliposomes, the estimated inhibition constant of ~20-40
µM was quite high. However, in the reconstituted
Escherichia coli bo3 oxidase, 10 µM ZnSO4 gave significant inhibition (12).
Recent studies on purified RsCcO show two
different inhibitory effects on steps in the reaction cycle (13) with high and low affinities for Zn2+. Similarly,
Paracoccus denitrificans oxidase shows evidence of Zn2+ sites that affect proton uptake steps in the reaction
cycle similar to those identified in the purified Rs oxidase
(14).
The studies reported here demonstrate that there is a zinc
binding site on the external side (P side) of the oxidase that is
strongly inhibitory in the presence of a membrane potential (
,
negative inside), but whose inhibitory effect is much diminished when
the electrical potential is removed. The zinc inhibition of
RsCcO in lipid vesicles is readily reversed by a
water-soluble chelator, demonstrating that the zinc site is external
and solvent accessible. We suggest that the potential-sensitive
inhibitory effect involves blockage of a proton exit path.
 |
EXPERIMENTAL PROCEDURES |
Preparation of Cytochrome c Oxidase--
Cytochrome c
oxidase was purified from Rhodobacter sphaeroides as
previously reported (15) using an Ni2+-NTA-agarose (Qiagen)
affinity step followed by a further fast protein liquid chromatography
(Amersham Biosciences, Inc., AKTA-519) purification procedure with
tandem DEAE-5PW columns (Toso-Haas) (16). Bovine heart oxidase was
purified by the Yoshikawa method (17). Site-directed mutants were made
previously (M263LII (18); D132AI (19);
D407AI and R481KI (20); H277AI
(21); R234H/CII, D412AI, and
H411QII (22, 23); and
H93C/NI 2 and subunit
III-less oxidase (24)) and purified in the same way as wild-type.
Reconstitution of cytochrome c oxidase vesicles (COVs) was
performed using a dialysis method, giving a final concentration of 20 mg/ml asolectin (recrystallized from Associated Concentrates using the
procedure of Sone et al. (25)) and 2 µM
oxidase in 50 µM HEPES-KOH, pH 7.4, + 44 mM
KCl + 38 mM sucrose. Alternatively, purified COVs were made
using an oxidase construct with a His-tag on subunit II
(htIICcO) that is able to bind to an Ni2+-NTA
affinity chromatography column for isolation and concentration of COVs
with correctly oriented oxidase, as described in Hiser et
al. (16). Basically, detergent was removed by a Sephadex G-25
column equilibrated with 75 mM HEPES-KOH, pH 7.4, +14
mM KCl. The COVs were collected and diluted into 20 mM HEPES-KOH, pH 8.0, 27 mM KCl and 38 mM sucrose, and the pH was adjusted to 8.0 with KOH before
addition to Ni2+-NTA-agarose. Vesicles containing correctly
oriented oxidase bound to the column and were eluted with 20 mM HEPES-KOH, pH 7.4, 100 mM histidine, 38 mM sucrose. Histidine and buffer were removed by
concentration of the COVs on a Centriplus 100 centrifugal spin filter
(Amicon) and dialyzed against 2 × 1000 volumes for 6 h each
of 50 µM HEPES-KOH, pH 7.4, 45 mM KCl, and 44 mM sucrose. The concentration of oxidase in the purified
vesicles was calculated from the dithionite-reduced spectrum at 605 nm
using an extinction coefficient of 33.35 mM
1
cm
1 after background baseline subtraction (26).
ZnSO4 was from Columbus Chemical Industries, Inc., and all
other metals used were of ACS grade. Na-EDTA (Invitrogen) at pH 7.4 was
used as a chelator.
Steady-state Measurements--
Oxygen consumption was measured
with a Gilson oxygraph at 25 °C using ascorbate, TMPD (Kodak), and
horse heart cytochrome c (Sigma), which further was purified
using carboxymethylcellulose ion-exchange chromatography (27).
Zinc inhibition constants (KI) were calculated from
the fits of the data using non-linear least-squares fitting in Microcal
Origin to 1 or 2 inhibitory binding sites using the equations,
|
(Eq. 1)
|
for uncontrolled COV measurements, and,
|
(Eq. 2)
|
for controlled COV and purified enzyme.
The data from the steady-state kinetics of cytochrome
c reaction with controlled COVs was fitted in Microcal
Origin to Michaelis-Menten plots using the equation for two cytochrome
c binding sites (28),
|
(Eq. 3)
|
Stopped-flow Measurements--
Measurements of cytochrome
c oxidation were made in an Olis-rsm stopped-flow
apparatus with COVs. Scans were collected (1000/s), and from
these the rates of cytochrome c oxidation (550 nm) were fit
either using Global analysis or by single-exponential fitting to the
kinetic traces using Microcal Origin. The electron donor was
pre-reduced horse heart cytochrome c made by sodium
dithionite reduction followed by desalting and depolymerizing through a
Sephadex G-75 (Amersham Biosciences, Inc.) gel filtration column into
0.5 mM HEPES-KOH, pH 7.4, + 45 mM KCl + 1 mM Na-EDTA.
Proton Pumping Measurements--
Proton pumping measurements
were made as described previously (16). Scans were collected, and
kinetic traces for cytochrome c oxidation at 550 nm or
phenol red changes at 557 nm (isosbestic point of cytochrome
c) were extracted after averaging at least three data sets
and creating difference spectra (reduced minus oxidized). A small
mixing artifact at 0-200 ms was subtracted from the phenol red changes
(16). Rates of proton uptake or release were measured by fitting the
kinetic traces for phenol red at 557 nm to one exponential with
Microcal Origin. The cytochrome c oxidation rates were
obtained from Global fitting analysis by the Olis software to a
single-component exponential and were similar to those obtained from
the kinetic traces at 550 nm, but the latter were more perturbed by the
influence of the phenol red absorbance.
 |
RESULTS |
Membrane Potential Effects on Zinc Inhibition--
The inhibition
with zinc was examined with cytochrome c oxidase
reconstituted in lipid vesicles to physically separate the outside of
the enzyme (P side) from the inside (N side). Measurements of
cytochrome c oxidation with reconstituted
cytochrome-c oxidase (COVs) were made: (a) in the
controlled condition (no ionophores added; i.e. with
pH
and 
), (b) with valinomycin (no 
), and (c) in the uncontrolled state with uncoupler (no
pH or

) (Fig. 2). It was immediately
obvious that zinc was more effective in inhibiting the controlled
state, in stopped-flow measurements with few or many turnovers. This
was also true in steady-state measurements of oxygen consumption, where
increasing ZnSO4 concentrations revealed a
KI of ~5 µM, reaching ~75%
inhibition in the controlled state at 300 µM
ZnSO4 (Fig.
3A).

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 2.
Inhibition of reconstituted R. sphaeroides cytochrome c oxidase activity
by ZnSO4. COVs (0.05 µM
aa3 final concentration) ± 240 µM ZnSO4 were mixed in the Olis-rsm
stopped-flow apparatus with 10 µM cytochrome
c2+ and scans collected (1000 scans/s) in
50 mM HEPES-KOH + 24 mM KCl, pH 7.4. Kinetic
traces at 550 nm are shown from an average of three data sets.
Controlled state (A), with 2 µM valinomycin
(B), or uncontrolled state with valinomycin + 10 µM CCCP (C).
|
|

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 3.
Differential inhibition by nickel and zinc of
purified enzyme compared with COVs. Steady-state measurements of
ZnSO4 (solid lines) or NiSO4
(dashed lines) inhibition were made as described under
"Experimental Procedures" with increasing metal added immediately
prior to the addition of TMPD, ascorbate, enzyme, and 30 µM horse heart cytochrome c. A,
controlled (no ionophores); B, uncontrolled states (+1
µM valinomycin + 6 µM FCCP), COVs (14 nM aa3), 5.7 mM
ascorbate, and 0.28 mM TMPD were added. C,
purified enzyme (2 nM aa3), 0.05%
lauryl maltoside, 1.4 mM ascorbate, and 1.1 mM
TMPD were added. The inset to B shows the full
range of metal concentrations tested with the uncontrolled COVs. The
data from at least two separate measurements is fitted to 1 or 2 binding sites as under "Experimental Procedures."
|
|
Zinc also inhibited after the addition of nigericin, which removes the
pH leaving a 
, both in steady-state and stopped-flow measurements where activity was decreased ~60% with 100 µM zinc. Zinc was much less inhibitory when valinomycin
or uncoupler was added (KI ~ 1 mM)
(Fig. 3B). In the purified, unreconstituted enzyme, the
activity profile with increasing zinc (Fig. 3C) fit to two
inhibition constants (KI ~ 9 µM
and ~ 400 µM). The effect of zinc on bovine
heart-controlled COVs (data not shown) was less potent, giving
inhibition constants of ~ 25 µM and in the
millimolar range, similar to the earlier report (11).
Inhibition by Zn2+ was reversed by addition of Na-EDTA
under all conditions and within the dead-time of mixing in the
stopped-flow apparatus, indicating that zinc binds on the
outside of the enzyme surface and is solvent-accessible.
In the controlled state, slight additional inhibition at very high
concentrations of zinc (KI ~ 1-2 mM)
was discerned from biphasic fitting of the data of Fig. 3A,
but this was likely due to vesicle aggregation, which can be monitored
by light-scattering changes. Examination for these scattering effects
showed substantial vesicle aggregation with 5 µM
poly-L-lysine but no measurable effect up to 100 µM Zn2+, indicating that vesicle aggregation
is not a factor in the zinc inhibition at the lower concentrations.
The question of whether Zn2+ inhibition is mediated by
binding to the phospholipid membrane rather than the oxidase was
addressed by altering the phospholipid composition of the vesicles.
When the asolectin vesicles were supplemented with 25%
phosphatidylcholine (neutral charge) or 25% phosphatidylserine
(negative charge), the resulting COVs gave an unchanged inhibition
constant with Zn2+ (KI
5 µM), arguing against a lipid-mediated effect. Further
evidence that Zn2+ inhibition involves direct interaction
with the RsCcO rather than the membrane comes
from comparison of normal and htIICcO-purified vesicles,
where the lipid-to-CcO ratio is decreased 10-fold. The decrease in lipids did not affect the KI for
Zn2+. Specific zinc inhibition of the controlled state was
observed whether the histidine-tag, used for purification of the
overexpressed enzyme, was on subunit I and therefore on the inside of
the COVs or on subunit II at the C-terminal end (htIICcO) on
the outside of the COVs (16), implying that the His-tag is not also
involved in zinc inhibition.
Metal Specificity--
A comparison of nickel and zinc in the
controlled state (Fig. 3A) showed that, although nickel
appears to bind with high affinity to the outside of oxidase its
inhibition is limited, only inhibiting to 20% even at high metal
concentrations. Unlike the Ni2+ binding on the outside of
COVs, Ni2+ strongly inhibits with medium affinity (~40
µM) the purified enzyme (Fig. 3C) but lacks
the low affinity binding site seen with Zn2+.
Other divalent cations were found to be either non-inhibitory beyond
ionic strength effects (Mg2+, Mn2+,
Ca2+, Ba2+, Li2+, Cs2+,
Tb3+, Tm3+), or slightly inhibitory
(Hg2+>Ni2+>Co2+), with only
Cd2+ being as effective as Zn2+ (data not shown
with the exception of Co2+, Ca2+, and
Zn2+ in Table I). These results indicate a specific
interaction and not, for example, an effect of ionic strength. This was
verified by the measurement of steady-state turnover of the oxidase
with high concentrations of Ca2+, which did not remove the
inhibition by zinc (data not shown). Neither was it an effect on the
interaction of cytochrome c with the oxidase, as shown by
examining the kinetics of interaction of cytochrome c in the
absence or presence of zinc (Fig. 4).
This result clearly shows that addition of zinc in the micromolar range to controlled COVs reduces the Vmax from 900 to
600 e
/s/aa3. However, from the
negative inverse of both of the slopes in the Eadie-Scatchard plot and
from the fitting of the Michaelis-Menten plot (as under "Experimental
Procedures," not shown), there was no significant effect on the
Km values for cytochrome c
(Ka = 0.04 µM and
Kb = 0.8 µM) with or without zinc.
These apparent Michaelis constants are similar to those published for
free enzyme (28).

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 4.
Zinc is not competitive with the substrate
cytochrome c. Measurements of oxygen consumption
activity were made with oxidase reconstituted into vesicles with no
ionophores added (controlled state) in the Gilson oxygraph, as
described under "Experimental Procedures," in the absence ( ,
upper line) or presence ( , lower line) of 29 µM ZnSO4. The slope of the linear fits are
1/Km, and the Vmax is the
x intercept.
|
|
The purified oxidized enzyme or COVs after turnover with reduced
cytochrome c were examined by EPR (electron paramagnetic resonance): the CuA and heme a spectra revealed
no changes with zinc addition up to millimolar concentrations (data not shown).
Zinc Inhibits Various Low Activity CcO Mutants--
To investigate
the nature of zinc inhibition, mutants with already low activity due to
blockage at varying sites were examined for additive Zn2+
effects. A mutant of the D channel path (D132AI), has very
low activity, normally 5% of wild-type activity when comparing the
rates of the purified enzymes, and does not pump protons (19, 29, 30).
In vesicles under controlled conditions, D132A (15 e
/s/aa3) has 15% of the wild-type
rate. D132A is inhibited by zinc to an even lower rate (4 e
/s/aa3) with a similar
KI as wild-type (Table
I). The D132AI mutant is
rate-limited by blockage of proton uptake from the inside via the
D-path, but there is substantial evidence that protons can
be supplied from the outside at a slow rate that is stimulated by the
membrane potential (19, 30). The rate of proton uptake from the outside
for D132AI COVs, observed as an alkalinization of the
vesicle exterior in the controlled condition, is the same as the
electron transfer rate (Table II) whether
or not Zn2+ is added. In the wild-type COVs, this apparent
proton leak rate, under controlled conditions, is much slower than the
electron transfer rate, because proton uptake from the inside is
supporting activity and pumping. But the addition of Zn2+
slows the electron transfer rate to that of the alkalinization rate,
similar to the D132AI mutant. A mutation of the
CuA ligand, M263LII, has very low activity due
to a 100-mV increase in the CuA redox potential (31, 32).
Zn2+ also inhibited this mutant to a similar extent (to 5 e
/s/aa3 with 250 µM
Zn2+) as D132AI (Table I). Also,
Zn2+ inhibits a mutant, R481K, which already has high
respiratory control.
View this table:
[in this window]
[in a new window]
|
Table I
Zinc inhibits the controlled condition and increases the respiratory
control ratio
Measurements of cytochrome-c oxidase activity in COVs
prepared by dialysis in 50 mM HEPES-KOH + 24 mM KCl, pH 7.4, with 0.1 µM oxidase and 5 µM cytochrome c2+ in the stopped-flow
Olis-rsm apparatus with 240 µM metal added where
indicated. Rates are from Global analysis of the averaged three data
sets for each condition.
|
|
View this table:
[in this window]
[in a new window]
|
Table II
Measurements of cytochrome c oxidation and phenol red changes with
controlled COVs in the stopped-flow Olis-rsm
Under these conditions (no ionophores) there is no proton pumping but
substrate protons are still consumed for the reduction of oxygen to
H2O, and protons leak from the outside causing alkalinization.
Rates are shown from the average of three data sets as either
e /s/aa3 for cytochrome c
oxidation (from Global analysis) or H+/s/aa3
for protons (calculated as under "Experimental Procedures") with
errors from the standard deviation of the fits. Metals were added to a
final concentration of 250 µM (CaCl2 or
ZnSO4) with 0.1 µM oxidase with 5 µM cytochrome c2+. These measurements
were made with Ni2+-NTA purified COVs as for Fig. 6.
|
|
Localization of the Zinc Binding Site--
In an effort to
identify the zinc binding site, various mutants of outside sites were
examined for their ability to be inhibited by zinc in the controlled
state after reconstitution. The preferred ligands for zinc are
cysteines, histidines, carboxyls, carbonyls, other charged groups, and
H2O (33). There are only a few conserved charged residues
on the outside of oxidase, excluding the cytochrome c
binding site on subunit II. The subunit I mutants H277LI,
H411QI, D412AI, and D407AI retained
inhibition by zinc (Fig. 1). Mutations of a surface histidine
(H93C/NI) were made, above heme a close to the
aspartate 51 in the bovine oxidase. This region has been identified as
having an altered conformation in the reduced versus
oxidized crystal structures of the bovine enzyme and was suggested to
be the proton exit site (34). However, the reconstituted H93 mutants
were still inhibited by zinc. Additionally, a mutant that lacked
subunit III (Cox III(
)) (24) was inhibited by zinc, eliminating
subunit III as a candidate for the external zinc binding site.
Respiratory Control and Zinc Inhibition--
In stopped-flow
measurements of cytochrome c oxidation, zinc inhibition was
decreased from ~85% at 240 µM Zn2+ to 5%
after the addition of valinomycin, which equilibrates potassium across
the membrane to dissipate the 
, to wild-type COVs (Table I). Upon
further removal of both 
and
pH with valinomycin and the
uncoupler FCCP (uncontrolled condition), little inhibition was seen.
This differential inhibition of the controlled state results in a very
high respiratory control ratio (RCR = 44) for the wild-type COVs
with Zn2+ added (Table I) whereas the normal RCR for
wild-type is expected to be from 6 to 10. Certain oxidase mutants show
unusually low RCRs, such as the subunit II mutant M263LII,
which normally has an RCR of 2-3. The RCR for M263LII
oxidase is increased with Zn2+ but only to 7, because the
uncontrolled rate of electron transfer is extremely limited (31, 32).
Other mutants, such as R481KI, show unusually high RCR
values (Table I) that are further increased by Zn2+.
Reasons for the changes in RCR in various mutants are not entirely clear, but arginine 481 is part of a hydrogen-bonded network above the
hemes and interacts with the heme propionates that have been implicated
as participants in the exit path for protons (35). When the arginine is
mutated to a lysine (R481K), it yields an enzyme that appears normal
and is able to efficiently pump protons but is more strongly controlled
by
pH and 
3 similar
to a Zn2+-inhibited state. Zn2+ further
inhibits the R481KI mutant oxidase in the controlled
condition (Table I), giving an exceedingly high RCR of 54. Interestingly, the ba3 oxidase from
Thermus thermophilus gives a low stoichiometry of proton pumping but has a naturally high RCR of ~40 (36).
The D channel oxidase mutant D132AI, when reconstituted
into vesicles, has unusual properties (19, 29, 30). Unlike the native
enzyme, where activity is stimulated by removal of the 
/
pH , this mutant oxidase is most active under the controlled condition. The
D channel is severely compromised in D132AI, but its
remaining activity appears to be supported by protons from the outside
(P side). When 
and
pH are present, there is a driving force
for inward proton movement from the outside, stimulating
D132AI activity (though it only achieves 15% of the normal
activity). Because of this, the D132AI mutant shows reverse
respiratory control: i.e. RCR < 1. Interestingly, addition of Zn2+ to the D132AI COVs led to
restoration of normal respiratory control, due to strong inhibition of
the controlled rate (Table I). The restoration of a normal RCR with
D132AI COVs was not observed with the addition of
Ni2+ (KI ~ 10 µM), which
is much less inhibitory (maximum only 20% at mM
Ni2+ concentration) and may not bind at the same site as
Zn2+. It was shown in the bacterial reaction center that
zinc and cadmium bound to the same sites, but that nickel and cobalt
were bound differently and were less inhibitory (37).
Zinc Is Competitive with Protons--
A pH profile of the activity
of COVs measured by stopped-flow in the controlled condition
demonstrates a characteristic sigmoidal curve with an inflection point
at approximately pH 6.8 (Fig. 5). However, after zinc addition this pKa was no longer
observed, with zinc inhibition increasing at higher pH and considerably less inhibition below pH 6.5. When these data are plotted as activity versus [H+] (Fig. 5, inset),
Zn2+ inhibition shows a linear response with H+
concentration, suggesting direct competition of protons for the zinc
site. This pH effect was observed with steady-state measurements (not
shown). A 10-fold increase in zinc inhibition occurs in going from pH 6 to 7, as previously observed for zinc binding to the voltage-gated
H+ channel from rat alveolar epithelial cells (38). Because
of vesicle aggregation at pH less than 6, we were unable to appraise the effect of zinc at pH 5-6, which caused a 100-fold difference in
the inhibition of zinc in the voltage-gated H+ channel. In
earlier studies with bovine heart COVs (11), this pH dependence was not
seen, perhaps reflecting a difference in the binding sites between the
bacterial and mammalian enzymes.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 5.
Protons compete with zinc binding. The
cytochrome c oxidation rate of controlled COVs was measured
(average of three data sets) with no metal added or with 240 µM ZnSO4 at different pH outside. COVs (0.1 µM aa3 final concentration) in 50 µM HEPES-KOH, pH 7.4, + 45 mM KCl were
rapidly mixed, in the stopped-flow apparatus, with cytochrome
c2+ in 50 mM of the appropriate
buffer (MES, pH 6-7/HEPES, pH 7-8.5/CHES, pH 8.5-9) with constant
ionic strength maintained by the addition of KCl, to give a final
mixture of 25 mM buffer and 45 mM
K+ in the range pH 6-9. The inset shows the
same data plotted with substrate proton [H+] × 10 7 M concentration to show the linearity of
the response when zinc is added.
|
|
Zinc Reduces the Rate and Extent of Proton Pumping--
For
stopped-flow proton pumping measurements, COVs were used that had been
purified through an Ni2+-NTA column so that vesicles with
correctly oriented oxidase were separated from wrongly oriented and
empty vesicles to minimize any artifacts from excess lipids (16).
Proton pumping is normally measured in the presence of valinomycin
where zinc is much less inhibitory (Table I). COVs show normal proton
pumping with CaCl2 (H+/e
~ 1)
(Fig. 6B), but the rate and
extent of proton release was diminished by 40-50% with
Zn2+ (Fig. 6D). When uncoupler (FCCP) is added,
normal alkalinization (increased phenol red absorbance) was observed
with Ca2+, but again at a somewhat reduced rate with
Zn2+ (Fig. 6, A and C, respectively).
The D132AI COVs still showed no proton pumping with the
addition of Zn2+ (data not shown) despite the positive
respiratory control ratio.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 6.
Proton pumping of COVs is not blocked by
Zn2+ but is less efficient.
Ni2+-NTA-purified htIICcO COVs were used in the
Olis-rsm stopped-flow with 0.1 µM oxidase and 5 µM cytochrome c2+ and 100 µM phenol red dye in 50 µM HEPES-KOH, pH
7.4, + 45 mM KCl (average of three data sets). A
and B, phenol red changes with 250 µM
CaCl2; C and D, phenol red changes
with 250 µM ZnSO4 as above; A and
C, alkalinization after uncoupling by the addition of 2 µM valinomycin +5 µM FCCP (pumped protons
are not seen, and the alkalinization is due to substrate protons
consumed to make H2O); B and D,
acidification due to proton pumping in the presence of 2 µM valinomycin to alleviate build-up of the  . The
arrow shows the decrease in absorbance with acidic
outside.
|
|
 |
DISCUSSION |
External Zinc Binding in R. sphaeroides CcO: pH Dependence, Metal
Specificity, Relation to Other Zinc Sites--
Zinc inhibits
cytochrome c oxidase reconstituted into vesicles by binding
to an outside, solvent-exposed surface site, most strongly when there
is a membrane potential present. Zinc binding does not compete with
cytochrome c binding and does not appear to interact with
the histidine-tag, because there is an equal response to zinc with or
without the histidine-tag on the outside. However, zinc inhibition
decreases with increasing proton concentrations (low pH) in a manner
that suggests that zinc is competed off by protons (Fig. 5). This is
reminiscent of the results obtained with the bc1
complex (39), voltage-gated H+ channel (38), and in the
N-methyl-D-aspartate receptor NR2A subunit, where, in the latter case, the pH-dependent
inhibition by zinc was attributed to a single histidine (40). These
results would suggest that, at the external site in oxidase, zinc is
specifically bound to at least one amino acid ligand that is
protonatable with a pKa of 6-7. The pH dependence,
plus the inability of other divalent cations to inhibit the
reconstituted oxidase, argues against a non-protein binding site
involving membrane phospholipids. A similar specificity for
Zn2+ and Cd2+ is observed for various
voltage-gated H+ channels and for the membrane proteins
that contain proton paths that are inhibited by zinc (4,
38-41).
The external zinc binding site in oxidase is probably not the calcium
site, not only because of the lack of competition with other metals,
but because no inhibitory effect on activity has been shown with metals
at the calcium site. In the Paracoccus and probably in the
RsCcO, the calcium site remains inaccessible to
solvent (42), unlike the zinc site. Additionally, zinc inhibition was
observed with the reconstituted E. coli bo3
terminal quinol oxidase (12), which does not have a calcium site (42).
The rapid release of Zn2+ inhibition by EDTA demonstrates
that the observed effects are not due to internalization of the
Zn2+ under the influence of the membrane potential.
Brzezinski's group (13) has found that zinc also inhibits the
unreconstituted RsCcO with a
KI ~ 3 µM in the last and slowest
step (F
O, >1 ms) of the cycle when CO is flashed off the fully
reduced oxidase in the presence of O2. This step has a high
deuterium isotope effect,
kH/kD of 8 (43), suggesting
that it is rate-limited by a protonation event. Additionally, there is
a medium affinity zinc binding site (KI = 120 µM, P
F) that is presumed to be at a separate site.
However, in the reconstituted oxidase there is no medium affinity site for zinc in the 10
4 M range, although there
is a similarly high affinity site for zinc. The high affinity site
measured in the free enzyme is unlikely to be the same site as that
observed with the reconstituted enzyme because of the release of
inhibition by removal of the membrane potential and its much lower
sensitivity to nickel (Fig. 2A).
CuA is situated in the soluble domain of subunit II close
to the membrane/solvent interface and could be affected in its redox properties if zinc bound in the vicinity (12). However, in the purified, oxidized enzyme or in controlled COVs that were frozen after
multiple turnovers with reduced cytochrome c and zinc, we see no perturbation of the EPR spectra of CuA and heme
a. Additionally, the mutant M263LII already has
a very different CuA redox state (100 mV higher than normal) (31, 32), and yet it is further inhibited by zinc binding. If
zinc is inhibiting by binding close to the CuA site, a
further additive effect on the redox state of CuA would be
required or competition with cytochrome c binding would be
expected but is not observed.
The high affinity zinc site (0.5 µM) in the bacterial
reaction center (3) is formed by 2 histidines, a glutamate, and one water ligand with tetrahedral coordination (4), similar in structure to
a catalytic zinc site (44). Interestingly, nickel and cobalt are not
bound to the same site as zinc in the bacterial reaction center,
although they share one histidine ligand (4) and there is a difference
in both the affinity and the mode of inhibition between zinc and nickel
(45). This would suggest that the electronic configuration is important
for coordination and metal selectivity. Nickel does inhibit
the controlled state of COVs, but the inhibition is minor (10-20%
maximum), suggesting some distinctive characteristics of its binding
site compared with Zn2+. On the other hand, the inside
binding has similar inhibition characteristics for both
Ni2+ and Zn2+ (Fig. 2C) providing an
important distinguishing feature between the exterior and interior
interactions. The
5 µM affinity of zinc on the outside
of RsCcO suggests similarity to the zinc site observed in the crystal structure of the chicken
bc1 complex, which has a KI ~ 3 µM and appears to involve a histidine and an
aspartate (46).
There are only a few histidines or charged amino acids on the outside
surface that are conserved between bovine, RsCcO,
and E. coli bo3 oxidases and that are not
critical for cytochrome c binding. Site-directed mutants of
potential zinc binding residues exposed to the outside were examined
for their ability to bind zinc in the reconstituted COVs in the
controlled state: D407AI, H277AI,
H411QI, D412AI, and H93I (within 5 Å of a glutamate 182I) (Fig. 1), and the subunit III-less
deletion strain (24). All of the mutant oxidases were inhibited by
zinc. We are in the process of making mutations to test other potential
ligands but recognize the handicap that there may be a different
conformation of the region of interest in the presence of the membrane potential.
Mechanism of Zinc Inhibition--
It has been documented that the
KA hippocampal neuronal channel only binds zinc at high affinity (~3
µM) when the membrane is hyperpolarized with a large
negative 
(41). The suggestion is that a conformational change
occurs in the mouth of the channel altering the accessibility of at
least one of the key amino acids involved in zinc binding. Similarly,
the reconstituted oxidase could undergo a conformational change in the
presence of a 
that alters the proton exit path such that zinc
binding is favored. Alternatively, zinc could remain bound in the
absence of a 
but have little effect on activity in the latter
state. It is difficult to directly measure zinc binding under these
conditions, so we have not ruled out this possibility.
The normal assay for proton pumping by cytochrome c oxidase
requires addition of valinomycin, thought to prevent the buildup of a
membrane potential that would inhibit observable (net) proton extrusion. But valinomycin also reduces the inhibitory effect of zinc.
Possibly, pumped protons coming out through the exit path effectively
compete with zinc for binding. However, the D132AI mutant,
which does not appear to pump protons, is also less inhibited when
there is no 
, arguing against this interpretation and in favor of
the conformational effect of 
.
Conformational change in cytochrome c oxidase was previously
proposed to involve at least two states differing in protonation of the
enzyme (47, 48). This idea arose from experimental evidence suggesting
that the oxidase is altered by the membrane potential or by the
reduction of the redox-active metal centers, particularly
CuA and heme a.
We propose that zinc inhibition in the controlled state is caused by
prevention of the proton movement through the exit pathway which is
essential for electron transfer. The requirement for charge
neutralization of the electron transfer events involving protonatable
groups in the oxidase has already been proposed (49, 50). Blockage of
proton movement (from inside or outside) to and from key residues could
inhibit the electron transfer rate or prevent the supply of protons to
the active site or prevent a through-protein back-leak that could be a
determinant of controlled respiration (51). Interesting recent results
from Kannt et al. (14) raise this possibility as well.
Inhibition by zinc on the inside of the Paracoccus COVs was
reported to affect respiratory control. In fact, we were able to
reproduce these findings with Rs COVs but also observed that
addition of EDTA to the external medium removed the effect on RCR
without altering the overall inhibitory effect. From this we conclude
that the external binding of zinc is responsible for the effects on
respiratory control.
In all of the systems that are inhibited by zinc, even where the zinc
site is known, it has been difficult to define the exact mechanism of
zinc inhibition. It has been proposed that zinc could physically block
a channel (3, 39), alter the pKa of groups important
in H+ movement (45), prevent conformational mobility of a
group (52), or control a gating event (53). At the fairly high
concentrations required to get significant inhibition, metal binding to
the oxidase is not likely to be physiologically important, but it may
reveal the location of the proton exit path. We are continuing to
investigate the mechanism of zinc inhibition.
Respiratory Control Is Modulated by Changes on the
Outside--
Classically, the rate of electron transfer in
mitochondria under controlled conditions (with a membrane potential)
has been thought to be governed by the rate of passive leakage of
protons across the lipid bilayer (54). The inhibition by zinc of this controlled rate, with metal specificity, micromolar affinity, and
reversibility, argues strongly against this idea, as does the lack of
effect of varying the nature and quality of the lipid membrane. The
leakage of protons into or through the protein itself appears to be a
more tenable hypothesis, also supported by evidence from native and
mutant bacterial oxidases with widely varying RCR values. Most notable
is ba3 oxidase of T. thermophilus,
which displays RCRs of 40-50 (36) when measured at 25 °C, well
below the normal temperature for this thermophilic bacterium. It is reasonable to assume that the enzyme is in a rigid conformation at this
low temperature, limiting motion that could be important for
determining the level of controlled activity. Similarly, the interaction of zinc on the outside of the RsCcO
oxidase could fix certain residues in an inflexible state.
The phenomenon of reverse respiratory control, exhibited by the
D132AI mutant of RsCcO, provides
additional evidence of proton uptake from the outside that is
stimulated by a membrane potential (29) and inhibited by zinc. This
back-leak is able to support oxidase activity and thus feeds protons to
some residue(s) that are normally supplied by proton uptake from the
inside through the D pathway.
The control of proton back-leak through the oxidase has
been suggested as a plausible mechanism of regulating the efficiency of
cytochrome c oxidase (55). This mechanism invokes
conformational control of the reversibility of the exit pathway,
perhaps mediated in the mammalian enzyme by allosteric effectors such
as ATP and phosphorylation (56). The data in this report raise the
possibility that zinc could also be a physiological regulator of proton
back-leak in CcO. A physiological role for zinc in
inhibiting respiration of liver mitochondria has been postulated (2).
Metallothionein has been shown to mediate zinc delivery to the
mitochondrial intermembrane space, where it is capable of inhibiting
respiration at micromolar concentrations.
The sum of available data indicates that zinc blocks proton movement in
the exit path of CcO, in the presence of an electrical potential gradient and with a high degree of metal specificity. Identification of the zinc binding site on the exterior of
CcO may give us an important clue regarding the location of
the proton exit pathway and how it may contribute to oxidase regulation.
 |
ACKNOWLEDGEMENTS |
We thank Dr. Honggao Yan for help with the
equations for fitting the zinc and cytochrome c binding
data. We also thank Sarah Cloutier for excellent technical assistance.
Additionally, we acknowledge Dr. Peter Nicholls, Dr. Sasha
Konstantinov, Dr. Peter Brzezinski, and Dr. Neil Law for helpful
discussions on various aspects of zinc and oxidase.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grant R37-GM26196 (to S. F. M.).The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Current address: St. Mary's Mercy Medical Center, Pathology Dept.,
Grand Rapids, MI 49503.
To whom correspondence may be addressed: Dept. of Biochemistry,
Michigan State University, East Lansing, MI 48824-1319. Tel.: 517-353-3512; Fax: 517-353-9334; E-mail: millsden@pilot.msu.edu.
¶
To whom correspondence may be addressed: Dept. of
Biochemistry, Michigan State University, East Lansing, MI 48824-1319. Tel.: 517-355-0199; Fax: 517-353-9334; E-mail:
fergus20@pilot.msu.edu.
Published, JBC Papers in Press, February 6, 2002, DOI 10.1074/jbc.M111922200
2
C. Hiser and S. Ferguson-Miller, unpublished.
3
D. A. Mills, J. Qian, and S. Ferguson-Miller, unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
CcO, cytochrome c oxidase;
CCCP, carbonylcyanide-m-chlorophenylhydrazone;
COVs, cytochrome
oxidase-containing phospholipid vesicles;
FCCP, carbonylcyanide-p-trifluoromethoxy-phenylhydrazone;
htIICcO, cytochrome c oxidase with a His-tag on
subunit II C-terminal;
MES, 2-(N-morpholino)ethanesulfonic
acid;
Ni2+-NTA, nickel nitrilotriacetic acid;
RCR, respiratory control ratio;
Rs, R. sphaeroides;
TMPD, N,N,N',N'-tetramethyl-p-phenylenediamine;
RsCcO, Rhodobacter sphaeroides
cytochrome c oxidase;
CHES, 2-(cyclohexylamino)ethanesulfonic acid.
 |
REFERENCES |
| 1.
|
Outten, C.,
and O'Halloran, T.
(2001)
Science
292,
2488-2492[Abstract/Free Full Text]
|
| 2.
|
Ye, B.,
Marte, W.,
and Vallee, B.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
2317-2322[Abstract/Free Full Text]
|
| 3.
|
Paddock, M.,
Graige, M.,
Feher, G.,
and Okamura, M.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
6183-6188[Abstract/Free Full Text]
|
| 4.
|
Axelrod, H.,
Abresch, E.,
Paddock, M.,
Okamura, M.,
and Feher, G.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
1542-1547[Abstract/Free Full Text]
|
| 5.
|
Iwata, S.,
Ostermeier, C.,
Ludwig, B.,
and Michel, H.
(1995)
Nature
376,
660-669[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Ostermeier, C.,
Harrenga, A.,
Ermler, U.,
and Michel, H.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
10547-10553[Abstract/Free Full Text]
|
| 7.
|
Tsukihara, T.,
Aoyama, H.,
Yamashita, E.,
Tomizaki, T.,
Yamaguchi, H.,
Shinzawa-Itoh, K.,
Nakashima, R.,
Yaono, R.,
and Yoshikawa, S.
(1996)
Science
272,
1136-1144[Abstract]
|
| 8.
|
Florens, L.,
Hoganson, C.,
McCracken, J.,
Fetter, J.,
Mills, D. A.,
Babcock, G. T.,
and Ferguson-Miller, S.
(1999)
in
The Phototropic Prokaryotes
(Peschek, G. e. a., ed)
, pp. 329-339, Kluwer Acad., Plenum Publishers, New York, NY
|
| 9.
|
Wikström, M.,
Bogachev, A.,
Finel, M.,
Morgan, J. E.,
Puustinen, A.,
Raitio, M.,
Verkhovskaya, M. L.,
and Verkhovsky, M. I.
(1994)
Biochim. Biophys. Acta
1187,
106-111[Medline]
[Order article via Infotrieve]
|
| 10.
|
Lee, H.-M.,
Das, T.,
Rousseau, D.,
Mills, D.,
Ferguson-Miller, S.,
and Gennis, R.
(2000)
Biochemistry
39,
2989-2996[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Nicholls, P.,
and Singh, A. P.
(1988)
Life Sci. Adv. (Agra, India)
7,
321-326
|
| 12.
|
Kita, K.,
Kasahara, M.,
and Anraku, Y.
(1982)
J. Biol. Chem.
257,
7933-7935[Abstract/Free Full Text]
|
| 13.
|
Aagaard, A.,
and Brzezinski, P.
(2001)
FEBS Lett.
494,
157-160[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Kannt, A.,
Ostermann, T.,
Muller, H.,
and Ruitenberg, M.
(2001)
FEBS Lett.
503,
142-146[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Zhen, Y.,
Qian, J.,
Follmann, K.,
Hosler, J.,
Hayward, T.,
Nilsson, T.,
and Ferguson-Miller, S.
(1998)
Protein Expr. Purif.
13,
326-336[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Hiser, C.,
Mills, D. A.,
Schall, M.,
and Ferguson-Miller, S.
(2001)
Biochemistry
40,
1606-1615[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Yoshikawa, S.,
Tera, T.,
Takahashi, Y.,
Tsukihara, T.,
and Caughey, W. S.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
1354-1358[Abstract/Free Full Text]
|
| 18.
|
Zhen, Y.,
Wang, K.,
Kang, U. G.,
Millett, F.,
and Ferguson-Miller, S.
(1999)
Biophys. J.
76,
A237
|
| 19.
|
Fetter, J. R.,
Qian, J.,
Shapleigh, J.,
Thomas, J. W.,
García-Horsman, J. A.,
Schmidt, E.,
Hosler, J.,
Babcock, G. T.,
Gennis, R. B.,
and Ferguson-Miller, S.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
1604-1608[Abstract/Free Full Text]
|
| 20.
|
Qian, J.,
Shi, W.,
Pressler, M.,
Hoganson, C.,
Mills, D.,
Babcock, G. T.,
and Ferguson-Miller, S.
(1997)
Biochemistry
36,
2539-2543[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Hosler, J. P.,
Ferguson-Miller, S.,
Calhoun, M. W.,
Thomas, J. W.,
Hill, J.,
Lemieux, L., Ma, J.,
Georgiou, C.,
Fetter, J.,
Shapleigh, J. P.,
Tecklenburg, M. M. J.,
Babcock, G. T.,
and Gennis, R. B.
(1993)
J. Bioenerg. Biomembr.
25,
121-136[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Florens, L.,
McCracken, J.,
and Ferguson-Miller, S.
(1999)
Biophys. J.
76,
A238
|
| 23.
|
Mills, D. A.,
Florens, L.,
Hiser, C.,
Qian, J.,
and Ferguson-Miller, S.
(2000)
Biochim. Biophys. Acta
1458,
180-187[Medline]
[Order article via Infotrieve]
|
| 24.
|
Bratton, M.,
Pressler, M.,
and Hosler, J.
(1999)
Biochemistry
38,
16236-16245[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Smith, H. T.,
Staudenmayer, N.,
and Millett, F.
(1977)
Biochemistry
16,
4971-4974[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Vanneste, W. H.
(1966)
Biochemistry
5,
838-848[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Brautigan, D. L.,
Ferguson-Miller, S.,
and Margoliash, E.
(1978)
Methods Enzymol.
53,
128-164[Medline]
[Order article via Infotrieve]
|
| 28.
|
Zhen, Y.,
Hoganson, C. W.,
Babcock, G. T.,
and Ferguson-Miller, S.
(1999)
J. Biol. Chem.
274,
38032-38041[Abstract/Free Full Text]
|
| 29.
|
Fetter, J. R.,
Sharpe, M.,
Qian, J.,
Mills, D.,
Ferguson-Miller, S.,
and Nicholls, P.
(1996)
FEBS Lett.
393,
155-160[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Zhen, Y.,
Mills, D.,
Hoganson, C. W.,
Lucas, R. L.,
Shi, W.,
Babcock, G.,
and Ferguson-Miller, S.
(1999)
in
Frontiers of Cellular Bioenergetics: Molecular Biology, Biochemistry and Physiopathology
(Papa, S.
, Guerrieri, F.
, and Tager, J. M., eds)
, pp. 157-178, Plenum Press, New York
|
| 31.
|
Karpefors, M.,
Adelroth, P.,
Zhen, Y.,
Ferguson-Miller, S.,
and Brzezinski, P.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
13606-13611[Abstract/Free Full Text]
|
| 32.
|
Zhen, Y.,
Wang, K.,
Mills, D.,
Ferguson-Miller, S.,
and Millett, F.
(1997)
Biophys. J.
72,
A93
|
| 33.
|
Cowan, J. A.
(1997)
Inorganic Biochemistry: An Introduction
, 2nd Ed.
, pp. 1-63, Wiley-VCH, Inc., New York, NY
|
| 34.
|
Yoshikawa, S.,
Shinzawa-Itoh, K.,
Nakashima, R.,
Yaono, R.,
Yamashita, E.,
Inoue, N.,
Yao, M.,
Fei, M. J.,
Libeu, C. P.,
Mizushima, T.,
Yamaguchi, H.,
Tomizaki, T.,
and Tsukihara, T.
(1998)
Science
280,
1723-1729[Abstract/Free Full Text]
|
| 35.
|
Michel, H.
(1999)
Biochemistry
38,
15129-15140[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Kannt, A.,
Soulimane, T.,
Buse, G.,
Becker, A.,
Bamberg, E.,
and Michel, H.
(1998)
FEBS Lett.
434,
17-22[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Okamura, M. Y.,
and Feher, G.
(1992)
Annu. Rev. Biochem.
61,
861-896[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Cherny, V.,
and DeCoursey, T.
(1999)
J. Gen. Physiol.
114,
819-838[Abstract/Free Full Text]
|
| 39.
|
Link, T.,
and von Jagow, G.
(1995)
J. Biol. Chem.
270,
25001-25006[Abstract/Free Full Text]
|
| 40.
|
Low, C.-M.,
Zheng, F.,
Lyuboslavsky, P.,
and Traynelis, S. F.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
11062-11067[Abstract/Free Full Text]
|
| 41.
|
Kuo, C.-C.,
and Chen, F.-P.
(1999)
Biophys. J.
77,
2552-2562[Abstract/Free Full Text]
|
| 42.
|
Riistama, S.,
Laakonen, L.,
Wikstrom, M.,
Verkhovsky, M. I.,
and Puustinen, A.
(1999)
Biochemistry
38,
10670-10677[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Karpefors, M.,
Adelroth, P.,
and Brzezinski, P.
(2000)
Biochemistry
39,
6850-6856[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Alberts, I. L.,
Nadassy, K.,
and Wodak, S. J.
(1998)
Protein Sci.
7,
1700-1716[Abstract]
|
| 45.
|
Gerencser, L.,
and Maroti, P.
(2001)
Biochemistry
40,
1850-1860[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Berry, E.,
Zhang, Z.,
Bellamy, H.,
and Huang, L.
(2000)
Biochim. Biophys. Acta
1459,
440-448[Medline]
[Order article via Infotrieve]
|
| 47.
|
Brunori, M.,
Sarti, P.,
Colosimo, A.,
Antonini, G.,
Malatesta, F.,
Jones, M.,
and Wilson, M.
(1985)
EMBO J.
4,
2365-2368[Medline]
[Order article via Infotrieve]
|
| 48.
|
Thörnström, P.-E.,
Brzezinski, P.,
Fredriksson, P.-O.,
and Malmström, B. G.
(1988)
Biochemistry
27,
5441-5447[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
|
Mitchell, P.
(1976)
J. Theor. Biol.
62,
327-367[CrossRef][Medline]
[Order article via Infotrieve]
|
| 50.
|
Rich, P.,
Meunier, B.,
Mitchell, R.,
and Moody, R.
(1996)
Biochim. Biophys. Acta
1275,
91-95 |